Takeda Pharmaceutical Company halted production of a new type-2 diabetes drug due to dangerous side effects noted during experimentation. Actos Pioglitazone is a prescription drug used to treat diabetes. In 2008, it became one of the world’s best selling drugs despite safety concerns raised by the FDA. Many patients and their medical advisers were unaware […]

The FDA, general public and victims of Topamax side effects have been seeking justice for unlawful marketing in the pharmaceutical industry.

U.S. Drug Watchdog encourages recipients of faulty DePuy hip replacements to get tested to see if they have or will be experiencing premature hip failure. 

Many women don’t even realize that taking a selective serotonin reuptake inhibitor (SSRI) to treat depression while they are pregnant may have a negative effect on their baby.

In a study published in the May 15 issue of JAMA, researchers set out to determine the safety and long-term effectiveness of abdominal sacrocolpopexy, which the University of Michigan Von Voigtlander Women’s Hospital describes as “a surgery to correct the supporting muscles, ligaments and tissues of the vagina.”

Dr. Murray said that of the approximately 200 pelvic prolapse surgeries he conducts each year, 10 to 20 of them involve removing or repairing mesh that has caused health problems.

The American Urogynecologic Society (AUGS) has issued a statement opposing a potential ban of transvaginal mesh and recommending that it remain an option for treating POP.

On April 10, What’s Transvaginal Mesh, a website launched by personal injury lawyers across the country, published a press release that explains the details of pelvic organ prolapse – one of the conditions that the devices have been used to treat.

The issues with these devices are so widespread, however, that non-profit public broadcasting network PBS recently covered transvaginal mesh complications in its “Need to Know” series.